---
$id: https://graph.org.ai/products/commodity/51121927
$type: Product
source: UNSPSC
code: "51121927"
title: "Monoxerutin"
class: "51121900"
classTitle: "Drugs used for congestive heart failure"
family: "51120000"
familyTitle: "Antiarrythmics and antianginals and cardioplegics and drugs for heart failure"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Monoxerutin

**UNSPSC Code**: 51121927
**Class**: [Drugs used for congestive heart failure](Drugs used for congestive heart failure.mdx)
**Family**: [Antiarrythmics and antianginals and cardioplegics and drugs for heart failure](../Antiarrythmics and antianginals and cardioplegics and drugs for heart failure.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a flavonoid with the molecular formula C29H34O17, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier EKF7043SBU, chemically known as 3,3,4,5-tetrahydroxy-7-(2-hydroxyethoxy)flavone 3-(6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside) but more generally known as monoxerutin, which bears U.S. NIH Compound Identifier 5464100. European Medicines Agency schedules Monoxerutin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09053MIG. The term MONOXERUTIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules monoxerutin in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. MONOXERUTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

